SG Americas Securities LLC Takes $187,000 Position in Health Catalyst, Inc. (NASDAQ:HCAT)

SG Americas Securities LLC bought a new position in Health Catalyst, Inc. (NASDAQ:HCAT) during the 2nd quarter, Holdings Channel.com reports. The firm bought 29,294 shares of the company’s stock, valued at approximately $187,000.

Several other hedge funds also recently made changes to their positions in the company. Kennedy Capital Management LLC purchased a new stake in shares of Health Catalyst during the first quarter worth about $8,780,000. Primecap Management Co. CA raised its position in Health Catalyst by 26.7% during the 4th quarter. Primecap Management Co. CA now owns 1,419,577 shares of the company’s stock valued at $13,145,000 after purchasing an additional 299,139 shares during the last quarter. Essex Investment Management Co. LLC purchased a new stake in Health Catalyst in the 1st quarter worth approximately $1,848,000. ClariVest Asset Management LLC lifted its stake in Health Catalyst by 303.9% in the first quarter. ClariVest Asset Management LLC now owns 282,325 shares of the company’s stock worth $2,126,000 after acquiring an additional 212,425 shares during the period. Finally, Massachusetts Financial Services Co. MA boosted its holdings in Health Catalyst by 437.0% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 253,368 shares of the company’s stock valued at $2,346,000 after acquiring an additional 206,184 shares in the last quarter. 85.00% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Health Catalyst

In related news, COO Daniel Lesueur sold 5,209 shares of the firm’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $6.19, for a total value of $32,243.71. Following the sale, the chief operating officer now owns 150,006 shares in the company, valued at $928,537.14. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders sold 13,035 shares of company stock worth $81,396 over the last three months. 2.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the stock. Piper Sandler reduced their price target on shares of Health Catalyst from $15.00 to $14.00 and set an “overweight” rating on the stock in a research report on Thursday, June 6th. Cantor Fitzgerald restated an “overweight” rating and set a $16.00 price target on shares of Health Catalyst in a research report on Tuesday, August 20th. Stephens reduced their price target on Health Catalyst from $8.00 to $7.00 and set an “equal weight” rating on the stock in a research note on Thursday, August 8th. Evercore ISI lowered their price objective on Health Catalyst from $9.00 to $8.00 and set an “outperform” rating for the company in a research report on Tuesday, July 9th. Finally, Wells Fargo & Company reduced their target price on shares of Health Catalyst from $14.00 to $13.00 and set an “overweight” rating on the stock in a research report on Friday, May 10th. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $11.50.

Health Catalyst Stock Performance

NASDAQ:HCAT opened at $7.27 on Friday. The firm has a market cap of $429.18 million, a P/E ratio of -3.93 and a beta of 1.32. Health Catalyst, Inc. has a fifty-two week low of $5.42 and a fifty-two week high of $12.05. The firm has a 50-day simple moving average of $6.67 and a two-hundred day simple moving average of $7.09.

Health Catalyst (NASDAQ:HCAT) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $0.12 earnings per share for the quarter, topping analysts’ consensus estimates of $0.08 by $0.04. The company had revenue of $75.90 million during the quarter, compared to analyst estimates of $74.96 million. Health Catalyst had a negative net margin of 35.56% and a negative return on equity of 11.86%. The firm’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same period in the previous year, the business earned ($0.21) EPS. On average, equities research analysts predict that Health Catalyst, Inc. will post -0.4 EPS for the current year.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.